PAR 1.82% 28.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION, page-241

  1. 285 Posts.
    lightbulb Created with Sketch. 82
    What is it with everyone attacking Paul Rennie. I will say it again PAR are not the only Bio that has been put behind time because of a once in a life time event. The people who continually go on about time delays need to do some research on how many Bio Techs are behind there timelines. Throw into this the FDA are overwhelmed and you have had an environment where most timelines are behind. I do agree that PAR could be a little more pro active with updated information, including timelines. Stop investing in the Bio world if you want a quick turnaround on your investment, they take time and sometimes a lot of time, but sometimes the reward far outweighs the wait.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.